| Record ID | ia:clinicalguidetop0000loug |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/clinicalguidetop0000loug/clinicalguidetop0000loug_marc.xml |
| Download MARC binary | https://www.archive.org/download/clinicalguidetop0000loug/clinicalguidetop0000loug_meta.mrc |
LEADER: 01568cam 2200445 a 4500
001 ocm55684249
003 OCoLC
005 20200523034541.0
008 040518s2004 enka b 001 0 eng
040 $aNLM$beng$cNLM$dYUS$dIAX$dBAKER$dCGC$dYDXCP$dOCLCF$dOCLCQ$dOCLCO
016 7 $a101254428$2DNLM
020 $a1904218091
020 $a9781904218098
035 $a(OCoLC)55684249
042 $anlmcopyc
050 14 $aRC280.P7$bL68 2004
060 00 $a2005 L-428
060 10 $aWJ 762$bL887c 2004
100 1 $aLoughlin, Kevin R.
245 10 $aClinical guide to prostate specific antigen /$cKevin R. Loughlin.
246 30 $aProstate specific antigen
260 $aChipping Norton, Oxfordshire :$bBladon Medical Pub.,$c2004.
300 $avii, 101 pages :$billustrations ;$c21 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references and index.
650 0 $aProstate-specific antigen.
650 0 $aProstate$xCancer.
650 12 $aProstate-Specific Antigen.
650 12 $aProstatic Neoplasms$xdiagnosis.
650 22 $aProstatic Neoplasms$xtherapy.
650 7 $aProstate$xCancer.$2fast$0(OCoLC)fst01079479
650 7 $aProstate-specific antigen.$2fast$0(OCoLC)fst01079512
938 $aBaker & Taylor$bBKTY$c48.00$d48.00$i1904218091$n0006529081$sactive
938 $aYBP Library Services$bYANK$n2237516
029 0 $aNLM$b101254428
029 1 $aAU@$b000027898242
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 31 OTHER HOLDINGS